Covid-19 vaccine

YSTH NHS FT collaborate in new Covid-19 vaccine trial

York and Scarborough Teaching Hospitals (YSTH) NHS FT are taking part in a study, trailing a new Covid-19 vaccine with the University of York and Tees, Esk and Wear Valleys NHS FT.

Researchers will compare a placebo vaccine with the study vaccine, with participants crossing over during the trial and receiving both. Participants will not know when they are receiving the placebo or the investigational vaccine.

The study will involve a total of 30,000 adult subjects globally, and locally about 150 people, aged between 18 and 40 who have not already had a vaccine for Covid-19.

York is one of nine locations across the UK taking part in the global trial and is a first for the city. The study will also involve Regional Clinical Research Network partners, and is supported by the National Institute for Health Research (NIHR). The trial, based at the University of York, will involve up to ten planned visits to the clinic over a two-year period, but this may be shorter depending upon the on-going results. 

Lydia Harris, Head of Research and Development at York and Scarborough Teaching Hospitals NHS FT, said: “York is rapidly expanding its research capabilities. The quality of our researchers, facilities and patient groups are allowing us to engage effectively in cutting edge research at an international level. We have come a long way in a very short period of time.

“Our staff are doing incredible work to support Covid-19 research studies and we are very proud to have made significant contributions to this global effort.”

Professor Charles Lacey from Hull York Medical School who is the Principal Investigator, leading the local team, said: “Clinical studies are important for medical advances. Current available vaccines are only available because of research study volunteers.

“Although there are several approved Covid-19 vaccines available, research is ongoing to provide more options, since all vaccines may work differently in providing protection against Covid-19. The vaccine we are trialling showed very exciting results in phase 1/2 studies.”  

NHE July/August 21

NHE July/August 21

Prioritising staff wellbeing

NHE’s July/August 2021 edition focuses on some of the key, defining aspects of a successful, supported health service: Mental Health & Workforce. Elsewhere, we take on the incredibly topical Infection Prevention and address the role which Pharma will play in both our NHS and wider health environment.

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all